Colette Balaam, CEO of The Hive Group US, is pleased to have joined BioNJ, an organization devoted to advancing the vital goals of the biotechnology industry in the state of New Jersey. In particular, BioNJ’s medical innovation initiative—Because Patients Can’t Wait^®— aligns beautifully with Hive’s strong emphasis on the patient experience in designing communications for both patients and healthcare providers. Learn more about BioNJ and the importance of patient-focused medical innovation:

The Value of Medical Innovation: The Patient’s Voice